EUVIMEDEUVIMED entdecken
Crossref

Is sarcopenia a predictor of overall survival in primary IDH-wildtype GBM patients with and without MGMT promoter hypermethylation?

SERHAT KORKMAZ, Emin Demirel

Neurology Asia · 2023-06 · 28 (2) · 409-415

DOI: 10.54029/2023rfy ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology Asia, 2023-06. Verfasst von SERHAT KORKMAZ und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this study, we aimed to examine the success of temporal muscle thickness (TMT) and masseter muscle thickness (MMT) in predicting overall survival (OS) in primary IDH-wild glioblastoma (GBM) patients with and without MGMT promoter hypermethylation through publicly available datasets.

Methods

We included 345 primary IDH-wild GBM patients with known MGMT promoter hypermethylation status who underwent gross-total resection and standard treatment, whose data were obtained from the open datasets. TMT was evaluated on axial thin section postcontrast T1-weighted images, and MMT was evaluated on axial T2-weighted images. The median TMT and MMT were used to determine the cut-off point.

Results

The findings showed that median TMT 9.5 mm and median MMT 12.7 mm determined the cut-off value in predicting survival. Both TMT and MMT values less than the median muscle thickness were negatively associated with OS (TMT

Zitieren

APA

KORKMAZ, S., & Demirel, E. (2023). Is sarcopenia a predictor of overall survival in primary IDH-wildtype GBM patients with and without MGMT promoter hypermethylation?. Neurology Asia, 28(2), 409-415. https://doi.org/10.54029/2023rfy

Vancouver

KORKMAZ S, Demirel E. Is sarcopenia a predictor of overall survival in primary IDH-wildtype GBM patients with and without MGMT promoter hypermethylation?. Neurology Asia. 2023;28(2):409-415. doi:10.54029/2023rfy

BibTeX
@article{KORKMAZ2023,
  author = {KORKMAZ, SERHAT and Demirel, Emin},
  title = {Is sarcopenia a predictor of overall survival in primary IDH-wildtype GBM patients with and without MGMT promoter hypermethylation?},
  journal = {Neurology Asia},
  year = {2023},
  volume = {28},
  number = {2},
  pages = {409--415},
  doi = {10.54029/2023rfy}
}
Kostenlos starten →